PRDM13 anticorps (N-Term)
-
- Antigène Voir toutes PRDM13 Anticorps
- PRDM13 (PR Domain Containing 13 (PRDM13))
-
Épitope
- N-Term
-
Reactivité
- Humain, Chien
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRDM13 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Chien
- Purification
- Purified
- Immunogène
- PRDM13 antibody was raised in rabbit using the N terminal of PRDM13 as the immunogen
- Top Product
- Discover our top product PRDM13 Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
PRDM13 Blocking Peptide, catalog no. 33R-3733, is also available for use as a blocking control in assays to test for specificity of this PRDM13 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- PRDM13 (PR Domain Containing 13 (PRDM13))
- Autre désignation
- PRDM13 (PRDM13 Produits)
- Synonymes
- anticorps MU-MB-20.220, anticorps PFM10, anticorps PR/SET domain 13, anticorps PR domain containing 13, anticorps PRDM13, anticorps prdm13, anticorps Prdm13
- Sujet
- PRDM13 may be involved in transcriptional regulation. Synonyms: Polyclonal PRDM13 antibody, Anti-PRDM13 antibody, PR domain containing 13 antibody, MU-MB-20.220 antibody, PFM10 antibody.
-